MYDA Advisors’s Ventyx Biosciences VTYX Stock Holding History

MYDA Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$328K	–	134
2022 Q4	$328K	Buy	+10,000	New	+$296K	0.2%	64

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MYDA Advisors's VTYX Position: Q1 2023 in Review

MYDA Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2023, closing a stake of 10,000 shares — an estimated $328K sold.

MYDA Advisors first reported a position in VTYX in Q4 2022 and held it in 1 quarter. The position peaked at $328K in Q4 2022. 146 funds tracked by Wall St. Rank hold VTYX as of Q1 2023.

MYDA Advisors reported no remaining Ventyx Biosciences position as of Q1 2023 after selling out during the quarter.
MYDA Advisors sold 10,000 Ventyx Biosciences shares in Q1 2023, an estimated $328K.
MYDA Advisors first reported a position in Ventyx Biosciences in Q4 2022 and held it in 1 quarter.
MYDA Advisors's Ventyx Biosciences position peaked at $328K in Q4 2022.
146 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2023.

Based on MYDA Advisors's 13F filing for Q1 2023, filed 12 May 2023.